Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Thomas

Showing results (581-590 of 792) with videos related to

Pageof 80
Sort By:
Swiss Medical Weekly|March 11, 2021
Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate studySandro Tiziano Stoffel, Roger von Moos, Beat Thürlimann, et al.
Shoulder & Elbow|March 22, 2021
Shoulder Pain Diagnosis, Treatment and Referral Guidelines for Primary, Community and Intermediate CareJonathan L Rees, Rohit Kulkarni, Amar Rangan, et al.
Nano Letters|February 23, 2010
Harvesting waste thermal energy using a carbon-nanotube-based thermo-electrochemical cellRenchong Hu, Baratunde A Cola, Nanda Haram, et al.
JAMA Oncology|December 8, 2022
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without IpilimumabJennifer L McQuade, Hans Hammers, Helena Furberg, et al.
The Oncologist|August 10, 2019
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF AlterationsAditya Bardia, Mrinal Gounder, Jordi Rodon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancerRonald B Natale, Sumitra Thongprasert, F Anthony Greco, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2024
Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world studyGabriel Dernbach, Daniel Kazdal, Lukas Ruff, et al.
Journal of Nephrology|June 18, 2025
Kidney transplant arteriopathy revisitedKatharina Wirths, Michael Thomas, Georg Dieplinger, et al.
Scientific Reports|April 11, 2023
Avatar-based patient monitoring improves information transfer, diagnostic confidence and reduces perceived workload in intensive care units: computer-based, multicentre comparison studyLisa Bergauer, Julia Braun, Tadzio Raoul Roche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 13, 2025
Prognostic scores for patients with multiple brain metastases treated with repeated stereotactic radiosurgery - a secondary analysis of the CYBER-SPACE randomized phase 2 trialAnnabella Schiele, Denise Bernhardt, Thomas Welzel, et al.
Pageof 80

Showing results (581-590 of 792) with videos related to

Sort By:
Pageof 80
Swiss Medical Weekly|March 11, 2021
Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate studySandro Tiziano Stoffel, Roger von Moos, Beat Thürlimann, et al.
Shoulder & Elbow|March 22, 2021
Shoulder Pain Diagnosis, Treatment and Referral Guidelines for Primary, Community and Intermediate CareJonathan L Rees, Rohit Kulkarni, Amar Rangan, et al.
Nano Letters|February 23, 2010
Harvesting waste thermal energy using a carbon-nanotube-based thermo-electrochemical cellRenchong Hu, Baratunde A Cola, Nanda Haram, et al.
JAMA Oncology|December 8, 2022
Association of Body Mass Index With the Safety Profile of Nivolumab With or Without IpilimumabJennifer L McQuade, Hans Hammers, Helena Furberg, et al.
The Oncologist|August 10, 2019
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF AlterationsAditya Bardia, Mrinal Gounder, Jordi Rodon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancerRonald B Natale, Sumitra Thongprasert, F Anthony Greco, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2024
Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world studyGabriel Dernbach, Daniel Kazdal, Lukas Ruff, et al.
Journal of Nephrology|June 18, 2025
Kidney transplant arteriopathy revisitedKatharina Wirths, Michael Thomas, Georg Dieplinger, et al.
Scientific Reports|April 11, 2023
Avatar-based patient monitoring improves information transfer, diagnostic confidence and reduces perceived workload in intensive care units: computer-based, multicentre comparison studyLisa Bergauer, Julia Braun, Tadzio Raoul Roche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 13, 2025
Prognostic scores for patients with multiple brain metastases treated with repeated stereotactic radiosurgery - a secondary analysis of the CYBER-SPACE randomized phase 2 trialAnnabella Schiele, Denise Bernhardt, Thomas Welzel, et al.
Pageof 80